These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3973822

  • 21. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB, Lovejoy DB, Watts RN, Richardson DR.
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [Abstract] [Full Text] [Related]

  • 22. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [Abstract] [Full Text] [Related]

  • 23. Hemosiderosis in rodents and the effect of acetohydroxamic acid on urinary iron excretion.
    Corden BJ.
    Exp Hematol; 1986 Nov; 14(10):971-4. PubMed ID: 3770104
    [Abstract] [Full Text] [Related]

  • 24. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [Abstract] [Full Text] [Related]

  • 25. The treatment of animal models of malaria with iron chelators by use of a novel polymeric device for slow drug release.
    Golenser J, Domb A, Teomim D, Tsafack A, Nisim O, Ponka P, Eling W, Cabantchik ZI.
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1127-35. PubMed ID: 9190845
    [Abstract] [Full Text] [Related]

  • 26. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
    Tsafack A, Golenser J, Libman J, Shanzer A, Cabantchik ZI.
    Mol Pharmacol; 1995 Feb; 47(2):403-9. PubMed ID: 7870051
    [Abstract] [Full Text] [Related]

  • 27. Effects of kojic acid on oxidative damage and on iron and trace element level in iron-overloaded mice and rats.
    Kotyzová D, Eybl V, Koutenský J, Brtko J, Glattre E.
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S41-4. PubMed ID: 15141975
    [Abstract] [Full Text] [Related]

  • 28. Hydroxamate-based iron chelators: combinatorial syntheses of desferrioxamine B analogues and evaluation of binding affinities.
    Poreddy AR, Schall OF, Osiek TA, Wheatley JR, Beusen DD, Marshall GR, Slomczynska U.
    J Comb Chem; 2004 Mar; 6(2):239-54. PubMed ID: 15002973
    [Abstract] [Full Text] [Related]

  • 29. Stereoselective synthesis of natural N-(1-Deoxy-D-beta-fructos-1-yl)-L-amino acids and their effect on lead decorporation.
    Huo C, Wang C, Zhao M, Peng S.
    Chem Res Toxicol; 2004 Aug; 17(8):1112-20. PubMed ID: 15310243
    [Abstract] [Full Text] [Related]

  • 30. Iron tissue and excreta changes induced by ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid) in dogs.
    Rosenkrantz H, Metterville JJ.
    J Lab Clin Med; 1980 May; 95(5):771-6. PubMed ID: 7365318
    [Abstract] [Full Text] [Related]

  • 31. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [Abstract] [Full Text] [Related]

  • 32. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
    [Abstract] [Full Text] [Related]

  • 33. Synthesis of labelled small peptide complexes for imaging agents with technetium-99m and biodistribution in mice.
    Qi CM, Guo XF, Zhang HB, Li B, Jin W, Dai M.
    Yao Xue Xue Bao; 2002 Jul; 37(7):522-6. PubMed ID: 12914321
    [Abstract] [Full Text] [Related]

  • 34. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P.
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [Abstract] [Full Text] [Related]

  • 35. Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity.
    Chaston TB, Richardson DR.
    Am J Hematol; 2003 Jul; 73(3):200-10. PubMed ID: 12827659
    [Abstract] [Full Text] [Related]

  • 36. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
    Xu LC, Nakayama M, Harada K, Kuniyasu A, Nakayama H, Tomiguchi S, Kojima A, Takahashi M, Ono M, Arano Y, Saji H, Yao Z, Sakahara H, Konishi J, Imagawa Y.
    Bioconjug Chem; 1999 Jul; 10(1):9-17. PubMed ID: 9893958
    [Abstract] [Full Text] [Related]

  • 37. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD.
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB, Fridkin M, Zheng H.
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.